Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -97,336 | -77,073 | -46,040 | -22,078 | -61,656 |
| Depreciation Amortization | -1,226 | 374 | 239 | 115 | -918 |
| Accounts receivable | 174 | N/A | -5,000 | N/A | 1,427 |
| Other Working Capital | 15,958 | 15,279 | 9,269 | 3,861 | 3,461 |
| Other Operating Activity | 12,913 | 7,708 | 9,916 | 2,003 | 9,180 |
| Operating Cash Flow | $-69,517 | $-53,712 | $-31,616 | $-16,099 | $-48,506 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -805 | -701 | -421 | -180 | -1,063 |
| Purchase Of Investment | -251,815 | -175,049 | -132,313 | -79,763 | -347,537 |
| Sale Of Investment | 384,051 | 303,146 | 200,267 | 89,600 | 206,149 |
| Investing Cash Flow | $131,431 | $127,396 | $67,533 | $9,657 | $-142,451 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,007 | 1,243 | 789 | 574 | 230,421 |
| Other Financing Activity | -7,500 | -5,625 | -3,750 | -1,875 | -7,057 |
| Financing Cash Flow | $-4,493 | $-4,382 | $-2,961 | $-1,301 | $223,364 |
| Beginning Cash Position | 113,656 | 113,656 | 113,656 | 113,656 | 81,249 |
| End Cash Position | 171,077 | 182,958 | 146,612 | 105,913 | 113,656 |
| Net Cash Flow | $57,421 | $69,302 | $32,956 | $-7,743 | $32,407 |
| Free Cash Flow | |||||
| Operating Cash Flow | -69,517 | -53,712 | -31,616 | -16,099 | -48,506 |
| Capital Expenditure | -805 | -701 | N/A | -180 | -1,063 |
| Free Cash Flow | -70,322 | -54,413 | -31,616 | -16,279 | -49,569 |